D’Amico, A., Chen, M.-H., Sun, L., Lee, W. R., Mouraviev, V., Robertson, C., … Moul, J. (2010). 663 ADJUVANT VERSUS SALVAGE RADIATION THERAPY FOR PROSTATE CANCER AND THE RISK OF DEATH. In Journal of Urology (Vol. 183). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/j.juro.2010.02.1050

D’Amico, Anthony, Ming-Hui Chen, Leon Sun, W Robert Lee, Vladimir Mouraviev, Cary Robertson, Philip Walther, Thomas Polascik, David Albala, and Judd Moul. “663 ADJUVANT VERSUS SALVAGE RADIATION THERAPY FOR PROSTATE CANCER AND THE RISK OF DEATH.” In Journal of Urology, Vol. 183. Ovid Technologies (Wolters Kluwer Health), 2010. https://doi.org/10.1016/j.juro.2010.02.1050.

D’Amico A, Chen M-H, Sun L, Lee WR, Mouraviev V, Robertson C, et al. 663 ADJUVANT VERSUS SALVAGE RADIATION THERAPY FOR PROSTATE CANCER AND THE RISK OF DEATH. In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2010.

D’Amico, Anthony, et al. “663 ADJUVANT VERSUS SALVAGE RADIATION THERAPY FOR PROSTATE CANCER AND THE RISK OF DEATH.” Journal of Urology, vol. 183, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2010. Crossref, doi:10.1016/j.juro.2010.02.1050.

D’Amico A, Chen M-H, Sun L, Lee WR, Mouraviev V, Robertson C, Walther P, Polascik T, Albala D, Moul J. 663 ADJUVANT VERSUS SALVAGE RADIATION THERAPY FOR PROSTATE CANCER AND THE RISK OF DEATH. Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2010.